Oracle: A Growth Machine Facing Valuation Headwinds

GuruFocus.com2021-12-21

Mergers and acquisitions have been one of the top corporate themes of the year in 2021. Companies that have done well in recent years have been taking advantage of struggling companies, new startups ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2193131986?lang=zh_CN&edition=full","thumbnail":"https://s.yimg.com/uu/api/res/1.2/bNYPK2Iz47b52rNTLz.feA--~B/aD0yODI7dz00MjY7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/5K2P0cv02G7X0EpEcxQfpg--~B/aD0yODI7dz00MjY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d1464f554bfc34925ddf390d5fafd885","is_english":true,"pubTime":"2021-12-21 07:21","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2193131986","market":"us","top_or_hot":-1,"title":"Oracle: A Growth Machine Facing Valuation Headwinds","media":"GuruFocus.com","content":"<div>\n<p>Mergers and acquisitions have been one of the top corporate themes of the year in 2021. Companies that have done well in recent years have been taking advantage of struggling companies, new startups ...</p>\n\n<a href=\"https://finance.yahoo.com/news/oracle-growth-machine-facing-valuation-232115015.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oracle: A Growth Machine Facing Valuation Headwinds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOracle: A Growth Machine Facing Valuation Headwinds\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/oracle-growth-machine-facing-valuation-232115015.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Mergers and acquisitions have been one of the top corporate themes of the year in 2021. Companies that have done well in recent years have been taking advantage of struggling companies, new startups ...</p>\n\n<a href=\"https://finance.yahoo.com/news/oracle-growth-machine-facing-valuation-232115015.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4516","symbol_name":"特朗普概念","start_time":0,"source_url":"https://finance.yahoo.com/news/oracle-growth-machine-facing-valuation-232115015.html","article_id":"2193131986","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/bNYPK2Iz47b52rNTLz.feA--~B/aD0yODI7dz00MjY7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/5K2P0cv02G7X0EpEcxQfpg--~B/aD0yODI7dz00MjY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d1464f554bfc34925ddf390d5fafd885"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2193131986","pubTimestamp":1640042475,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Mergers and acquisitions have been one of the top corporate themes of the year in 2021. Companies th","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4516":"特朗普概念","BK4528":"SaaS概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓","BK4538":"云计算","BK4097":"系统软件","ORCL":"甲骨文","CERN":"美国塞纳","BK4167":"医疗保健技术","BK4534":"瑞士信贷持仓"},"translate_title":"甲骨文：面临估值逆风的增长机器","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CERN":1,"ORCL":0.9},"content_text":"Mergers and acquisitions have been one of the top corporate themes of the year in 2021. Companies that have done well in recent years have been taking advantage of struggling companies, new startups and record-low interest rates in order to make acquisitions that they hope will be value-accretive.\nIn most cases, these merger announcements have been followed by the stock price of the acquisition target rising to the acquisition price and the stock price of the acquiring company either booking modest gains or remaining flat.\n\nWarning! GuruFocus has detected 6 Warning Signs with ORCL. Click here to check it out. \nORCL 15-Year Financial Data\nThe intrinsic value of ORCL\nPeter Lynch Chart of ORCL\n\n\nHowever, there have been exceptions, and one of these exceptions has been software giant Oracle Corp.s (NYSE:ORCL) recently-announced plan to acquire electronic medical records company Cerner Corp. (NASDAQ:CERN).\nA difficult acquisition\nOn Friday, Oracle announced that it plans to acquire Cerner for $95 per share in cash, or approximately $28.3 billion in total equity value. The deal should close sometime in calendar 2022.\nOracle expects the deal to be immediately value accretive. It will be Oracles biggest acquisition ever, adding significant amounts of health data to its ever-growing cloud services business.\nOracles stock plunged 6% following the announcement, however. On Monday, the stock dropped another 5% to trade around $91.64, giving up the majority of its gains from earlier this month when it beat earnings estimates on both the top and bottom lines.\nMeanwhile, Cerner is still trading around the $90.49 mark, which is well below the $95 acquisition price. Its almost as if investors are betting that the deal will not be completed.\nAnalysts seem to be primarily concerned with two things about the Cerner acquisition. For one, the acquisition would be a heavy burden on Oracles already-strained balance sheet. The cash-debt ratio of 0.29 and the Piotroski F-Score of 3 out of 9 show a potentially unstable financial situation. Its possible that the company could end up having to finance the deal at least partially with stock, even if it valiantly tries the all-cash route first.\nThe second concern analysts have regarding the acquisition is that Cerner could harm Oracles growth story in the eyes of investors, leading to the market attributing the stock a lower valuation multiple. Cerners three-year revenue per share growth rate is 5.4% and its three-year Ebitda per share growth rate is 6.5%. These numbers are significantly below Oracles equivalent rates of 13% and 14.4%, respectively.\nThe valuation is out of line\nThe main values of the Cerner acquisition likely have to do with the companys health care data as well as a networking effect. However, those fearing a growth dilution may have a point. If the companys year-over-year growth rates begin to decline after the acquisition, investors may lose enthusiasm for the stock.\nThats not a good sign, especially since it is accelerated growth that has caused Oracles valuation multiples to increase in recent years. The stock currently trades for a price-earnings ratio of 26.57, which is higher than its 10-year median price-earnings ratio of 18.\nThe GuruFocus Value chart tells a similar story. Based on the combination of past returns, historical valuations and analyst estimates of future earnings, the GF Value chart rates the stock as modestly overvalued.\n  \nInvestors are losing faith\nOracles recent declines indicate that investors could be losing faith in its growth prospects. While the company should continue growing for many years to come, that growth might not match its current valuation multiples.\nAdditionally, Cerner trading below its acquisition price is a potential red flag. Anyone with faith that the deal will go through should theoretically be jumping on the easy money from the arbitrage opportunity. Normally, institutional investors close this gap long before retail investors even catch word of the acquisition.\nThere is another factor that is likely contributing to Oracles recent price declines. A broader market decline is ongoing as investors digest the spreading Omicron variant of Covid-19 as well as the U.S. Federal Reserves decision to hike interest rates next year. The S&P 500 was down 1% on Monday, with the majority of stocks in the index down 1% to 3% for the day.\nAll in all, while Oracle remains a leader in cloud services and will likely see many more years of growth, that growth could begin slowing down as more competitors enter the field and Oracle becomes a more mature company, focusing on slow and steady growth and shareholder returns over the speedy growth of the past. In light of this, value-focused investors who are interested in the stock may want to wait until the valuation falls more in line with historical averages.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2193131986"}